Sources

8 Total Sources

Pfizer Says Monthly Obesity Shot Posted 23.3% Vomiting Rate, Matching Wegovy-Like Side Effects

Left40%

Center40%

Right20%

Pfizer's Monthly Obesity Drug Berobenatide Shows Wegovy-Like Side Effects in Mid-Stage Trial

NBC News15h ago

Pfizer, Amgen Develop Monthly GLP-1 Weight Loss Drugs for Improved Convenience

StockTitan15h ago

Pfizer obesity drug shows 15.9% weight loss in Phase 2b | PFE Stock News

Yahoo! Voices15h ago

What to know about berobenatide, Pfizer's experimental obesity drug

What to know about berobenatide, Pfizer's experimental obesity drug - AOL

whalesbook.com15h ago

Pfizer Obesity Data Stokes Competitive Pricing Fears | Whalesbook

National Post15h ago

Pfizer Inc. is pulling back the curtain on its obesity ambitions | National Post

MD Magazine15h ago

Berobenatide Monthly Dosing Shows Weight Loss Efficacy in VESPER Trials, With John Buse, MD, PhD | HCPLive